NCT07185867 · NOT YET RECRUITING
Prevention of ANxiety and Depression Over Risk Assessment
This trial is testing two smartphone apps designed to prevent anxiety and depression before they start. One app is highly personalized with interactive modules on sleep, exercise, relationships, and emotional well-being. The other is a simpler educational version. Researchers will track whether either app reduces new diagnoses of anxiety or depression over 12 months. This is a Phase NA behavioral trial — it is evaluating a digital health tool, not a drug.
You may qualify if
- Informed consent acceptance
- Having a valid telephone number
- Ownership of an Apple-Android-operating smartphone with an internet connection
- 18-65 years old
- Habitually reside (> 6 months/year) in Spain or Chile
You're excluded if
- Difficulty reading and/or understanding Spanish
- Suffer from disabling neurological conditions (dementia, blindness, etc.) that makes it difficult to use smartphone, terminal illness with a life expectancy \< 12 months, a history of severe mental disorders confirmed by a healthcare professional (schizophrenia or psychosis, bipolar, anoxeria, bulimia or personality disorders), having alcohol or substance use disorder within the past year
- Currently receiving face to face or via internet psychological treatment (currently taking antidepressants or anxiolytics is not an exclusion criterion, but their use will be taken into account throughout the follow-up)
- Presence of clinically relevant anxiouys (GAD-7 score ≥ 10 points) or depressive symptoms (PHQ-9 score ≥ 10 points).
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-09-22